United Therapeutics (UTHR) Tops Q2 EPS by 24c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 601.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $601.32 | 52 Week High | $164.04 | |||
| Open | $601.32 | 52 Week Low | $97.52 | |||
| Day High | $601.32 | P/E | 109.93 | |||
| Day Low | $601.32 | EPS | $5.47 | |||
| Volume | 17,166 | |||||
